Ligand validation:6HWB

GWT: (2~{S})-~{N}-[(2~{S},3~{R})-1-(4-cyclohexylcyclohexyl)-4-methyl-3,4-bis(oxidanyl)pentan-2-yl]-3-(4-methoxyphenyl)-2-[[(2~{S})-2-(2-morpholin-4-ium-4-ylethanoylamino)propanoyl]amino]propanamide

GWT is a Ligand Of Interest in 6HWB designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HWB_GWT_Y_301	60%	6%	0.145	0.932	2.23	2.8	7	16	1	0	100%	1
6HWB_GWT_K_301	54%	7%	0.155	0.921	2.06	2.7	7	14	1	0	100%	1
6HWB_GWT_V_301	4%	28%	0.409	0.792	1.11	1.77	4	13	0	0	100%	0.4
6HWB_GWT_H_301	3%	9%	0.406	0.753	1.78	2.64	4	11	0	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.